Showing 37–48 of 110 results
-
API
GLP-1(9-37)98%
-
ADC
Irinotecan
-
ADC
Ixabepilone
-
API
Lanreotide
CAS:108736-35-2Status:DMF (2025)Indications:Tumors, as well as endocrine, nutritional, and metabolic diseases -
API
Liraglutide
CAS:204656-20-2
Status:DMF, TGA, NMPA, WC
Indications:Endocrine, nutritional, and metabolic diseases

